Literature DB >> 1968744

The episodic secretory pattern of growth hormone regulates liver carbonic anhydrase III. Studies in normal and mutant growth-hormone-deficient dwarf rats.

S Jeffery1, N D Carter, R G Clark, I C Robinson.   

Abstract

Carbonic anhydrase III (CAIII) occurs in male rat liver at concentrations twenty times those in the female, and is sensitive to the pattern of growth hormone (GH) release. Males release GH episodically and have high concentrations of CAIII; females produce GH in a more continuous fashion and have lower CAIII levels. In normal female rats, the endogenous GH secretory pattern was masculinized, either by regular injections of GH-releasing factor (GRF) or by intermittent infusions of somatostatin (90 min on/90 min off). Both treatments induced regular GH pulses and stimulated growth, but only intermittent somatostatin infusions raised CAIII levels (controls, 1.5 +/- 0.5; somatostatin-treated, 9.0 +/- 2.9 micrograms/mg; means +/- S.D.). GRF pulses (4 micrograms every 4 h) did not however raise CAIII levels (controls 1.8 +/- 0.5; GRF-treated 1.4 +/- 0.4 micrograms/mg). Surprisingly, hepatic CAIII is also sexually dimorphic (males, 18.8 +/- 3; females, 2.22 +/- 0.4 micrograms/mg) in a GH-deficient dwarf rat strain which has low plasma GH levels without 3-hourly GH peaks. Intermittent somatostatin infusions in female dwarf rats partially masculinized hepatic CAIII, an effect reduced by co-infusion with GRF. This CAIII response was not secondary to growth induction, since neither somatostatin nor GRF stimulated growth in dwarf rats, and pulses of exogenous GH stimulated growth in female dwarfs without masculinizing CAIII levels. Furthermore, continuous GH infusion in male dwarf rats partially feminized hepatic CAIII levels (to 9.1 +/- 2.4 micrograms/mg), whereas infusions of insulin-like growth factor-1, which induced the same body weight gain, did not affect hepatic CAIII (20.8 +/- 6 micrograms/mg). These results show that hepatic CAIII expression is highly sensitive to the endogenous GH secretory pattern, independent of growth. They also implicate the low basal GH levels between pulses, rather than the peak GH levels, as the primary determinant of the sexually dimorphic hepatic CAIII expression in the rat.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1968744      PMCID: PMC1131097          DOI: 10.1042/bj2660069

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  35 in total

1.  Growth hormone receptor and serum binding protein: purification, cloning and expression.

Authors:  D W Leung; S A Spencer; G Cachianes; R G Hammonds; C Collins; W J Henzel; R Barnard; M J Waters; W I Wood
Journal:  Nature       Date:  1987 Dec 10-16       Impact factor: 49.962

2.  Effects of hypophysectomy and growth hormone infusion on rat hepatic carbonic anhydrases.

Authors:  S Jeffery; C A Wilson; A Mode; J A Gustafsson; N D Carter
Journal:  J Endocrinol       Date:  1986-07       Impact factor: 4.286

3.  Growth hormone secretory profiles in conscious female rats.

Authors:  R G Clark; L M Carlsson; I C Robinson
Journal:  J Endocrinol       Date:  1987-09       Impact factor: 4.286

4.  Growth hormone-deficient dwarfism in the rat: a new mutation.

Authors:  H M Charlton; R G Clark; I C Robinson; A E Goff; B S Cox; C Bugnon; B A Bloch
Journal:  J Endocrinol       Date:  1988-10       Impact factor: 4.286

5.  Pulsatile intravenous growth hormone (GH) infusion to hypophysectomized rats increases insulin-like growth factor I messenger ribonucleic acid in skeletal tissues more effectively than continuous GH infusion.

Authors:  J Isgaard; L Carlsson; O G Isaksson; J O Jansson
Journal:  Endocrinology       Date:  1988-12       Impact factor: 4.736

Review 6.  Sexual dimorphism in the control of growth hormone secretion.

Authors:  J O Jansson; S Edén; O Isaksson
Journal:  Endocr Rev       Date:  1985       Impact factor: 19.871

7.  Imprinting of growth hormone secretion, body growth, and hepatic steroid metabolism by neonatal testosterone.

Authors:  J O Jansson; S Ekberg; O Isaksson; A Mode; J A Gustafsson
Journal:  Endocrinology       Date:  1985-11       Impact factor: 4.736

8.  Hypothalamo-pituitary regulation of cytochrome P-450(15) beta apoprotein levels in rat liver.

Authors:  C MacGeoch; E T Morgan; J A Gustafsson
Journal:  Endocrinology       Date:  1985-11       Impact factor: 4.736

9.  Automated repetitive microsampling of blood: growth hormone profiles in conscious male rats.

Authors:  R G Clark; G Chambers; J Lewin; I C Robinson
Journal:  J Endocrinol       Date:  1986-10       Impact factor: 4.286

10.  Paradoxical growth-promoting effects induced by patterned infusions of somatostatin in female rats.

Authors:  R G Clark; I C Robinson
Journal:  Endocrinology       Date:  1988-06       Impact factor: 4.736

View more
  5 in total

Review 1.  Potential applications of GH secretagogs in the evaluation and treatment of the age-related decline in growth hormone secretion.

Authors:  G R Merriam; D M Buchner; P N Prinz; R S Schwartz; M V Vitiello
Journal:  Endocrine       Date:  1997-08       Impact factor: 3.633

2.  Evidence from dwarf rats that growth hormone may not regulate the sexual differentiation of liver cytochrome P450 enzymes and steroid 5 alpha-reductase.

Authors:  P Bullock; B Gemzik; D Johnson; P Thomas; A Parkinson
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-15       Impact factor: 11.205

3.  Acetazolamide-insensitive carbonic anhydrase activities in liver and tonic skeletal muscle of adult male rats with streptozotocin-induced diabetes mellitus.

Authors:  J B Moynihan; S Ennis
Journal:  Biochem J       Date:  1990-12-01       Impact factor: 3.857

4.  Influence of the high-affinity growth hormone (GH)-binding protein on plasma profiles of free and bound GH and on the apparent half-life of GH. Modeling analysis and clinical applications.

Authors:  J D Veldhuis; M L Johnson; L M Faunt; M Mercado; G Baumann
Journal:  J Clin Invest       Date:  1993-02       Impact factor: 14.808

5.  Targeted overexpression of androgen receptor with a liver-specific promoter in transgenic mice.

Authors:  B Chatterjee; C S Song; M H Jung; S Chen; C A Walter; D C Herbert; F J Weaker; M A Mancini; A K Roy
Journal:  Proc Natl Acad Sci U S A       Date:  1996-01-23       Impact factor: 11.205

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.